Tech Company Financing Transactions
Captozyme Funding Round
Captozyme, based in Gainesville, secured $3.4 million from Sid Martin Biotechnology Institute.
Transaction Overview
Company Name
Announced On
3/17/2017
Transaction Type
Venture Equity
Amount
$3,400,000
Round
Series A
Investors
Sid Martin Biotechnology Institute (Mark Long)
Proceeds Purpose
The company plans to invest the funding in the manufacture and launch of Nephure�, an oxalate-degrading enzyme that facilitates a low-oxalate diet.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1622 NW 55th Pl.
Gainesville, FL 32653
USA
Gainesville, FL 32653
USA
Phone
Website
Email Address
Overview
Captozyme, Inc. is a biotechnology company dedicated to helping people better manage their diets and overall health. The company plans to launch Nephure in the spring of 2017.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Helena Cowley
Chief Operating Officer
Aaron Cowley
Chief Scientific Officer
Qing-Shan Li
VP - Marketing
Ryan Gerds
Browse more venture capital transactions:
Prev: 3/17/2017: eGenesis venture capital transaction
Next: 3/17/2017: NeuraLace venture capital transaction
Share this article
Where The Data Comes From
We record all VC transactions involving tech companies. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs